Oval Medical Technologies Limited
06810585
Some Concerns
- No accounts filed in last 18 months (-5)
- Negative net worth (-10)
- Going concern doubt noted in accounts (-10)
- 1 outstanding charge (-2)
Details
Compliance
Last accounts
31/12/2024
audit exemption subsidiary
Next accounts due
30/09/2026
Confirmation statement
Last: 05/02/2026
Due 19/02/2027
Industry
Officers
director · Since 10/12/2016
DIRECTOR
AMERICAN · UNITED STATES · Age 66
Also on 1 other board
director · Since 10/12/2016
DIRECTOR
AMERICAN · UNITED STATES · Age 67
Also on 1 other board
Persons with Significant Control
Smc Pharma Services Ltd
50/60, Station Road, Cambridge, CB1 2JH
Reg: 10446752 · Companies House England · Private Limited Company
Notified 10/12/2016
Charges1 outstanding
BARCLAYS SECURITY TRUSTEE LIMITED
CompanyRankvs 11010+ SIC 72200 peers37
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Risk deductions
Going concern doubt: -10 pts
Outstanding charges: -10 pts
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Going Concern Doubt
under section 400 of the Companies Act 2006 . Page 2 OVAL MEDICAL TECHNOLOGIES LIMITED NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023 2. ACCOUNTING POLICIES (CONTINUED) 2.4 GOING CONCERN The Company’s ability to continue trading relies on the continued financial support from its parent company, SMC Pharma Services Ltd (formerly Cambridge Pharma Services Ltd). At the bala
Key FinancialsYear ending 31/12/2023
Net Worth
-£411k
Balance sheet strength
Cash
£217k
Cash in the bank
Net Current Assets
£160k
Working capital
Current Assets
£984k
Current Liabilities
£823k
Fixed Assets
£2.7M
Debtors
£767k
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2023 | 1.19 | -£3.3M |
| 2022 | 1.39 | -£2.7M |
| 2021 | 0.75 | — |
Derived from filed accounts. Not audited figures.